Results 41 to 50 of about 1,169,427 (354)

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Cost analysis of cardiac MRI for cardiac transplant surveillance

JHLT Open
Background: Current heart transplant health surveillance relies on frequent cardiac catheterization with endomyocardial biopsy (cath-EMB) to detect acute rejection (AR).
Margaret M. Samyn, Ke Yan, Aspen Duffin, Kimberly Crum, Gail Stendhal, Justin Godown, Steve J. Kindel, Carly Lockard, Bruce Damon, Jonathan Soslow, John Affleck-Graves   +10 more
doaj   +1 more source

Cost savings following faecal microbiota transplantation for recurrent infection

Therapeutic Advances in Gastroenterology, 2019
Background: Recurrent Clostridium difficile infection (rCDI) is becoming increasingly common. Faecal microbiota transplantation (FMT) is effective for rCDI, but the costs of an FMT and hospital cost savings related to FMT are unknown.
Emilie Dehlholm-Lambertsen, Bianca K. Hall, Simon M. D. Jørgensen, Christine W. Jørgensen, Mia E. Jensen, Sara Larsen, Josephine S. Jensen, Lars Ehlers, Jens F. Dahlerup, Christian L. Hvas   +9 more
doaj   +1 more source

The Potential Savings to Social Security from Means Testing [PDF]

, 2011
Means testing, or reducing Social Security payments to affluent beneficiaries, has been touted as an effective way to reduce the cost of the program.
Dean Baker, Hye Jin Rho
core  

Crucial parameters for precise copy number variation detection in formalin‐fixed paraffin‐embedded solid cancer samples

Molecular Oncology, EarlyView.
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris, Vasiliki Siozopoulou, Léon C van Kempen, Anne Sieben, Ella Roelant, Stig Hellemans, Elyne Backx, Laure Sorber, Koen De Winne, Senada Koljenović, Karen Zwaenepoel   +10 more
wiley   +1 more source

Management of Lime in Steel

Metals, 2018
The EU28 total lime demand in 2017 was estimated at about 20 million tons, out of which about 40% are consumed in the iron and steel industry. Steel remains the major consumer after environment and construction.
Sanjeev Manocha, François Ponchon
doaj   +1 more source

FY2012 ICN report of savings [PDF]

, 2013
Iowa Code section 8D.10 requires certain state agencies prepare an annual report to the General Assembly certifying the identified savings associated with that state agency’s use of the Iowa Communications Network (ICN).

core  

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Cost savings associated with improving appropriate and reducing inappropriate preventive care: cost-consequences analysis

BMC Health Services Research, 2005
Background Outreach facilitation has been proven successful in improving the adoption of clinical preventive care guidelines in primary care practice. The net costs and savings of delivering such an intensive intervention need to be understood. We wanted
Baskerville Neill, Hogg William, Lemelin Jacques   +2 more
doaj   +1 more source

Clinical trials and drug cost savings for Italian health service

BMC Health Services Research, 2020
Background The cost of anticancer drugs is constantly growing. The aim of this study was determine the impact in terms of cost reduction for anticancer drug in the Italian Health Service due to patient participation in clinical trials.
Francesca D’Ambrosio, Gianfranco De Feo, Gerardo Botti, Arturo Capasso, Sandro Pignata, Piera Maiolino, Maria Triassi, Antonio Nardone, Franco Perrone, Michela Piezzo, Antonio Maria Grimaldi, Ida Palazzo, Immacolata De Stasio, Roberta D’Aniello, Alessandro Morabito, Giacomo Pascarella   +15 more
doaj   +1 more source